文献速递瓣膜外科

重新审视纵隔放疗后外科主动脉瓣置换术的作用

Reexamining the Role of Surgical Aortic Valve Replacement After Mediastinal Radiation Therapy.
PubMed 文献 · Ann Thorac Surg · 2017-04-26

单中心回顾性分析2000至2016年49例既往接受纵隔放疗后行主动脉瓣置换术(AVR)的患者,分为单纯AVR组18例和合并手术组31例。单纯AVR组院内死亡率0%,合并手术组16%(p=0.14);5年生存率单纯组65%±13%,合并组37%±11%(p=0.03)。结论认为单纯AVR可安全实施,但合并手术死亡率高且被传统风险评分低估,两组5年生存均显著受损。

要点

  • 纵隔放疗后单纯AVR院内死亡率0%,合并手术组16%。
  • 合并手术组5年生存率仅37%±11%,显著低于单纯组65%±13%。
  • 传统风险评分(Logistic EuroSCORE II 2.8%±3.4%,STS 1.7%±1.5%)低估合并手术风险。

核心结论

  • 纵隔放疗后单纯AVR可安全实施,而合并手术死亡率高且被传统风险评分大幅低估,两组5年生存均明显受损。

研究设计与样本

  • 单中心回顾性队列研究,纳入2000至2016年49例既往接受纵隔放疗后行AVR(伴或不伴合并手术)的连续患者。
  • 分为单纯AVR组(n=18)和AVR合并手术组(n=31),中位随访6.6年,研究关闭后12个月内随访完成率90%。

主要发现

  • 总体院内死亡率为10%(单纯组0% vs 合并组16%,p=0.14)。
  • 随访期间共21例(47%)死亡;单纯组平均死亡间隔2.0±1.1年,合并组1.4±1.6年(p=0.18)。
  • 单纯组1、3、5年生存率分别为93%±6%、73%±11%、65%±13%;合并组分别为74%±8%、44%±11%、37%±11%(p=0.03)。

关键数值与推荐

  • Logistic EuroSCORE II平均评分2.8%±3.4%,STS平均评分1.7%±1.5%。
  • 单纯AVR组院内死亡率0%,合并手术组16%(p=0.14)。
  • 5年生存率单纯组65%±13%,合并组37%±11%(p=0.03)。

临床怎么用

  • 对纵隔放疗后需AVR的患者,应优先考虑单纯AVR以降低手术风险。
  • 传统风险评分可能低估合并手术风险,术前评估需结合放疗病史谨慎决策。
  • 术后中期生存仍较差,需加强随访和长期管理。

局限性

  • 单中心回顾性研究,样本量小(49例),可能存在选择偏倚。
  • 两组基线特征未详细报告,混杂因素可能影响结果解释。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The risk of aortic valve replacement (AVR) for patients after mediastinal radiation therapy (MRT) remains unaccounted for in traditional risk scores. The aim of this study was to examine perioperative and midterm outcomes in patients undergoing AVR after MRT in the current era. METHODS: From 2000 to 2016, 49 consecutive patients previously exposed to MRT underwent AVR with or without concomitant procedures at a single center. Patients were divided into two groups: isolated AVR (n = 18) and AVR with concomitant procedures (n = 31). The logistic European System for Cardiac Operative Risk Evaluation II mean score was 2.8% ± 3.4% and The Society of Thoracic Surgeons mean score was 1.7% ± 1.5%. Median follow-up was 6.6 years and was 90% complete within 12 months of study closure. RESULTS: Overall inhospital mortality was 10% (0% in the isolated group versus 16% in the concomitant group; p = 0.14). A total of 21 patients (47%) died at follow-up. Mean interval to death was 2.0 ± 1.1 years from surgery in the isolated group versus 1.4 ± 1.6 years in the concomitant group (p = 0.18). Actuarial survival was 93% ± 6%, 73% ± 11%, and 65% ± 13%, at 1, 3, and 5 years, respectively, in the isolated group versus 74% ± 8%, 44% ± 11%, and 37% ± 11% in the concomitant group (p = 0.03). CONCLUSIONS: Isolated AVR can be performed safely in patients with MRT-induced disease. In contrast, AVR with concomitant procedures is associated with high mortality, which is vastly underestimated using traditional risk scores. In both groups, survival at 5 years is markedly impaired.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Ghoneim A, Bouhout I, Perrault LP, et al. Reexamining the Role of Surgical Aortic Valve Replacement After Mediastinal Radiation Therapy. Ann Thorac Surg. 2017. PMID: 28456394. doi:10.1016/j.athoracsur.2017.01.097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。